Articles

Podcasts

Videos

Endocrinology

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Advanced cystic fibrosis liver disease manifests as portal hypertension with or without cirrhosis in about 7% of patients with cystic fibrosis.

Ultrasounds Help Identify Advanced Cystic Fibrosis Liver Disease

In a pioneer study, investigators investigate if cannabis users had less incidence of pancreatic necrosis and/or pancreatic/peripancreatic fluid collections.

Cannabis Users With Acute Pancreatitis Less Likely to Have Necrosis, Fluid Collections

Roberto Simons-Linares, MD, presents new data at the annual ACG meeting on the association between hepatitis viral infections and acute pancreatitis.

Roberto Simons-Linares, MD: How a Hepatitis Viral Infection Causes Acute Pancreatitis

During the annual ACG meeting, Roberto Simons-Linares, MD explained how cannabis use impacts the fluids of patients suffering from acute necrotizing pancreatitis.

Roberto Simons-Linares, MD: The Impact of Cannabis Use for Acute Necrotizing Pancreatitis

The newly approved drug is a combination of 3 drugs that target the most common cystic fibrosis mutation.

FDA Approves Triple Therapy to Treat Cystic Fibrosis

The FDA had previously only certified Symdeko tablets for treatment of children aged 12 years and older.

FDA Approves Symdeko Tablets for Ages 6 and Older

Results connecting breathlessness catastrophizing with reduced quality of life also have implications for populations with asthma or COPD.

Catastrophizing and Cystic Fibrosis: Fear of Breathlessness Impacts Quality of Life

Upon finding pH and oxygen may influence how antibiotics perform in CF lung infections, investigators suggest a one-size-fits-all therapy approach may not be the best treatment.

Antibiotics for CF Lung Infections Influenced by Oxygen, pH

Investigators find telavancin has potent in vitro activity and low resistance development potential when used against S aureus isolates in patients with cystic fibrosis. 

Telavancin: Promising Treatment Option for MRSA in Cystic Fibrosis Patients?

Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.

Top 5 Rare Disease News of the Week&mdash;August 12, 2018

On the HCPLive exocrine pancreatic insufficiency page, resources on the topics of medical news and expert insight into EPI can be found. Content includes articles, interviews, videos, podcasts, and breaking news on the disease, and more.

Exocrine Pancreatic Insufficiency

Latest News